Hodgkin‐Inflammatory‐Based Model ME‐IPS Is a New Inflammatory‐Based Prognostic Model Calculated at Diagnosis: Results From a Real‐Life Study
Combining the ME-IPS model with PET-2 may provide a more effective tool for HL prognosis, particularly in cases of advanced disease, and guide treatment decisions in clinical practice.
Authors
- Fabio Palumbo (ORCID: https://orcid.org/0000-0002-7972-9819)
- Gabriella Santuccio
- Giovanna Motta (ORCID: https://orcid.org/0000-0001-5593-5397)
- Paolo Fabio Fiumara
- Alessandra Romano (ORCID: https://orcid.org/0000-0002-6333-4433)
- Amalia Figuera
- Anastasia Laura Caruso
- Francesco Di Raimondo (ORCID: https://orcid.org/0000-0002-7749-0293)
- Annalisa Chiarenza (ORCID: https://orcid.org/0000-0002-8759-4854)
- Vittorio Del Fabro (ORCID: https://orcid.org/0009-0000-4405-2716)
- Alessandro Petronaci
- Giuseppe A. Palumbo (ORCID: https://orcid.org/0000-0003-1859-6319)
- Andrea Duminuco (ORCID: https://orcid.org/0000-0002-9510-4755)
Institutions
- Università degli Studi di Enna Kore (IT)
- University of Catania (IT)
- Tecnologie Avanzate (Italy) (IT)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1111/ejh.70066
- Citations
- 2
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09